Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic demand has created supply challenges and affordability barriers for patients seeking GLP-1 weight loss therapy. PlexusDx provides clinically equivalent alternatives including compounded semaglutide and tirzepatide, both proven in randomized trials to reduce body weight by 15–22% over 68 weeks.

Why Patients Look Beyond Ozempic

Ozempic (semaglutide) remains in limited supply across the United States, with many pharmacies experiencing extended backorders. Beyond availability, the brand-name medication carries high out-of-pocket costs even with insurance coverage, often requiring prior authorization and copayments exceeding $200 per month.

Generic and compounded options deliver the same active pharmaceutical ingredient without the brand markup. Compounded medications are manufactured in licensed 503A pharmacies under the same FDA oversight standards that apply to brand-name drugs, ensuring purity and potency.

Compounded Semaglutide as an Ozempic Alternative

Compounded semaglutide injections contain identical semaglutide molecules to Ozempic but cost a fraction of the brand price. PlexusDx compounded semaglutide starts at $149 per month, with your dose able to increase as needed—your price remains the same across all dose levels.

Clinical trials demonstrate compounded semaglutide produces weight loss outcomes matching those of branded formulations. Patients typically see appetite reduction within 3–5 days and cumulative weight loss acceleration over 12–16 weeks as they titrate to their therapeutic dose.

Tirzepatide: A Dual-Action GLP-1/GIP Option

Tirzepatide activates two hormone pathways—GLP-1 and GIP—making it a more potent alternative for certain patients. The SURMOUNT trials showed tirzepatide achieved up to 22.5% body weight reduction, outperforming semaglutide alone in head-to-head comparisons.

PlexusDx compounded tirzepatide injection starts at $249 per month, and like semaglutide, dosing increases do not raise your monthly fee. Patients with genetic variants in GIPR or GLP1R genes may respond particularly well to tirzepatide's dual mechanism.

Oral Medications and Combination Therapies

Oral semaglutide ($249/month) and oral tirzepatide ($279/month) offer needle-free alternatives for patients uncomfortable with injections. While oral versions have slightly lower bioavailability than injectables, they remain clinically effective when taken on an empty stomach as directed.

PlexusDx also offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide, starting at $249/month for maximum flexibility and synergistic weight loss potential. For patients seeking a gentler entry point, the Microdose GLP-1 Protocol ($129/month) provides lower initial dosing while maintaining the same flat pricing model.

Genetic Testing to Optimize Your Choice

PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 49 peptides to identify which medication—semaglutide, tirzepatide, or a combination—aligns with your genetic predispositions. Key variants in GLP1R, GIPR, FTO, and MC4R genes influence how your body responds to each therapy.

Personalized genetic insights help reduce trial-and-error dosing and accelerate the path to your effective weight loss dose. Testing is available after your first month of treatment, allowing you to refine your therapy based on both clinical response and genetic data.

Cost, Access, and Payment Options at PlexusDx

All PlexusDx medications are available in all 50 states with no insurance requirement and no membership fees. Prescriptions ship directly from licensed 503A compounding pharmacies, with treatment starting within days of your telehealth consultation.

PlexusDx accepts HSA and FSA accounts, making weight loss therapy tax-advantaged for eligible patients. Monthly pricing remains flat regardless of dose adjustments, and no authorization delays or insurance denials can block access to your prescribed therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Ozempic?

Yes. Compounded semaglutide contains the identical active ingredient and achieves the same weight loss results in clinical use. The difference is manufacturing location (licensed compounding pharmacy versus pharmaceutical manufacturer) and cost, not efficacy.

What is the difference between semaglutide and tirzepatide?

Semaglutide targets the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and GIP receptors. Tirzepatide typically produces greater weight loss (up to 22.5% vs. 15% for semaglutide) but may cause more initial nausea. Your genetics and medical history help determine which is better for you.

How much does PlexusDx semaglutide cost compared to Ozempic?

PlexusDx compounded semaglutide starts at $149/month, compared to Ozempic copayments often exceeding $200/month even with insurance. PlexusDx requires no insurance, no prior auth, and no membership—just a flat monthly fee that covers all dose increases.

Are compounded medications from PlexusDx safe?

PlexusDx sources all medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight for sterility, potency, and purity. These standards are identical to those for brand-name medications. Your dose is customized by your assigned clinician and adjusted based on your response.

What is the Precision Peptide Genetic Test and how does it help?

PlexusDx Precision Peptide Genetic Test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R genes to predict whether you'll respond better to semaglutide, tirzepatide, or a dual-compound approach. For $99, this test eliminates guesswork and helps your clinician choose your optimal starting medication.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves